RESEARCH ARTICLE The efficacy of Jianpi Yiqi therapy for chronic atrophic gastritis: A systematic review and meta-analysis Yun-kai Dai1, Yun-zhan Zhang1, Dan-yan Li1, Jin-tong Ye1, Ling-feng Zeng2, Qi Wang2*, Ling Hu1* 1 Institute of Gastroenterology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China, 2 Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China a1111111111 a1111111111 *
[email protected] (LH);
[email protected] (QW) a1111111111 a1111111111 a1111111111 Abstract Jianpi Yiqi therapy (JYT) is a classical therapy in treating chronic atrophic gastritis (CAG), but the clinical effects of it are still contentious. The purpose of this article is to evaluate the OPEN ACCESS efficacy and safety of JYT for CAG. Seven electronic databases including PubMed, Citation: Dai Y-k, Zhang Y-z, Li D-y, Ye J-t, Zeng L- Embase, Springer Link, CNKI (China National Knowledge Infrastructure), VIP (Chinese Sci- f, Wang Q, et al. (2017) The efficacy of Jianpi Yiqi entific Journals Database), Wan-fang database, and CBM (Chinese Biomedicine Database) therapy for chronic atrophic gastritis: A systematic were searched from their inception to November 1, 2016. 13 randomized controlled trials review and meta-analysis. PLoS ONE 12(7): (RCTs) with a total of 1119 participants were identified for analysis. Meta-analyses demon- e0181906. https://doi.org/10.1371/journal. pone.0181906 strated that both JYT (RR 1.41; 95% CI 1.27, 1.57; P < 0.00001) and JYT + western medi- cine (RR 1.27; 95% CI 1.17, 1.38; P < 0.00001) were more efficacious than only western Editor: Ying-Ju Lin, China Medical University, TAIWAN medicine.